Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 5,304 shares at $499.99 ($2.6M) on 2026-02-13, disclosed to the SEC on 2026-02-18.
Scheduled sale ($2.6M) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $487.76 | 3,804 | $1.9M | 71.2% |
| 2 | $499.99 | 1,500 | $750K | 28.8% |
| Total | $491.22 avg | 5,304 | $2.6M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |
| VRTX | SELL | 2026-01-09 | $2.1M | — | Filing → |